The Quagmire that Nobody in the Federal Government Wants to Talk About: Marijuana

M. Reid
{"title":"The Quagmire that Nobody in the Federal Government Wants to Talk About: Marijuana","authors":"M. Reid","doi":"10.2139/SSRN.2271957","DOIUrl":null,"url":null,"abstract":"Legalization of marijuana has become the battle cry of many in the United States who are weary of the so-called “war on drugs” and are anxious for the federal government to allow them to use marijuana as their vice of choice. In the aftermath of several states choosing to legalize marijuana for medical use or for recreational use, the federal government must respond. Currently, both law enforcement and medical marijuana dispensaries at a standoff – law enforcement awaits orders to shut down dispensaries, and the dispensaries are risking potential seizure and the loss of their businesses. The federal government has three options: (1) legalize, (2) change marijuana from a Schedule I substance under the Controlled Substances Act to a Schedule II substance which would permit marijuana for medical purposes, or (3) enforce the current federal laws criminalizing the importation and distribution of marijuana. This article argues that option #2 is not viable and has been found to be problematic. Studies have revealed that the majority of those using marijuana with “medical cards” authorized by the state are not, in fact, using marijuana for medical purposes but rather, for recreational use. The drug cartels have gotten into bed with dispensaries and are operating without any restrictions or regulations placed on them. Moreover, marijuana cannot be changed to a Schedule II substance because the varying THC content in marijuana makes it impossible to monitor. This leads to choosing either option #1 or #2. Europe and Asia can inform this discussion. The general trend in Europe is one of prevention and decriminalization which is in stark contrast to Asia where the trend is focusing on punishment as a deterrent to drug use and distribution. The United States can look to other countries’ drug use policies to determine what has been proven to be effective. The federal government needs to take a stand and either crack down on the growing marijuana business or legalize and begin the arduous task of regulating and taxing while at the same time advocating for minimal use.","PeriodicalId":82111,"journal":{"name":"New Mexico law review","volume":"14 1","pages":"169"},"PeriodicalIF":0.0000,"publicationDate":"2013-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"New Mexico law review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2139/SSRN.2271957","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Legalization of marijuana has become the battle cry of many in the United States who are weary of the so-called “war on drugs” and are anxious for the federal government to allow them to use marijuana as their vice of choice. In the aftermath of several states choosing to legalize marijuana for medical use or for recreational use, the federal government must respond. Currently, both law enforcement and medical marijuana dispensaries at a standoff – law enforcement awaits orders to shut down dispensaries, and the dispensaries are risking potential seizure and the loss of their businesses. The federal government has three options: (1) legalize, (2) change marijuana from a Schedule I substance under the Controlled Substances Act to a Schedule II substance which would permit marijuana for medical purposes, or (3) enforce the current federal laws criminalizing the importation and distribution of marijuana. This article argues that option #2 is not viable and has been found to be problematic. Studies have revealed that the majority of those using marijuana with “medical cards” authorized by the state are not, in fact, using marijuana for medical purposes but rather, for recreational use. The drug cartels have gotten into bed with dispensaries and are operating without any restrictions or regulations placed on them. Moreover, marijuana cannot be changed to a Schedule II substance because the varying THC content in marijuana makes it impossible to monitor. This leads to choosing either option #1 or #2. Europe and Asia can inform this discussion. The general trend in Europe is one of prevention and decriminalization which is in stark contrast to Asia where the trend is focusing on punishment as a deterrent to drug use and distribution. The United States can look to other countries’ drug use policies to determine what has been proven to be effective. The federal government needs to take a stand and either crack down on the growing marijuana business or legalize and begin the arduous task of regulating and taxing while at the same time advocating for minimal use.
联邦政府里没人愿意谈论的泥潭:大麻
大麻合法化已经成为美国许多人的战斗口号,他们厌倦了所谓的“毒品战争”,迫切希望联邦政府允许他们使用大麻作为他们的选择。在几个州选择将大麻用于医疗或娱乐用途合法化之后,联邦政府必须做出回应。目前,执法部门和医用大麻药房都处于僵持状态——执法部门等待着关闭药房的命令,而药房则面临着可能被查封和失去业务的风险。联邦政府有三个选择:(1)将大麻合法化;(2)将大麻从《受控物质法案》中的附表1物质改为附表2物质,允许大麻用于医疗目的;或(3)执行现行的联邦法律,将大麻的进口和分销定为刑事犯罪。本文认为选项#2是不可行的,并且存在问题。研究表明,大多数持有国家授权的“医疗卡”使用大麻的人实际上并不是出于医疗目的使用大麻,而是出于娱乐用途。毒品卡特尔与药房勾结,在没有任何限制或规定的情况下运作。此外,大麻不能被改为附表II物质,因为大麻中不同的四氢大麻酚含量使其无法监测。这将导致选择选项1或选项2。欧洲和亚洲可以为这一讨论提供信息。欧洲的总体趋势是预防和非刑事化,这与亚洲的趋势形成鲜明对比,亚洲的趋势侧重于惩罚,以威慑毒品的使用和分发。美国可以参考其他国家的药物使用政策,以确定哪些已被证明是有效的。联邦政府需要采取立场,要么打击日益增长的大麻业务,要么将其合法化,并开始艰巨的监管和征税任务,同时提倡尽量减少使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信